Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suvorexant: Targeting Orexin to Augment Exposure Therapy in Veterans With PTSD and Insomnia

NCT07686731 is registered in ClinicalTrials.gov with Northern California Institute of Research and Education as lead sponsor.

NCT NCT07686731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07686731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suvorexant: Targeting Orexin to Augment Exposure Therapy in Veterans With PTSD and Insomnia
Lead sponsor
Northern California Institute of Research and Education
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
August 30, 2029
Enrollment
142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, ptsd - post traumatic stress disorder, tbi (traumatic brain injury)